Search PubMed⌕ Search

PubMed · 12856359

Knowing hatred.

Abstract

Hatred is known to be a common phenomenon and a lot has been written about this affect. However, the author believes that the more we read and write about hate the further away we find ourselves from a real sense of understanding of this so familiar and yet so elusive experience. She feels that using a single concept to describe 'hatred' seems to be a simplification of the matter, since it consists of a chain of affects that does not lend itself to easy theoretical or experiential distinction. In this paper the author aims at 'knowing' the experience of hatred as the individual's reaction to an unbearable existential excess, that is, as the psychic attempt to handle an emotional profusion in the context of human relation and in relation to it. The emotional abundance that the psyche cannot contain and process by itself is dealt with by the defensive use of simplification, detachment and distancing. An attempt is made to understand the relation between psychic existing and hatred, between craving, desiring and hate, between passionate aliveness--or a passion to live--and the difficulty in containing the excessive dimension of it. The author illustrates her thesis through a reading of Tolstoy's 'Kreutzer sonata' as a monologue of hatred.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rina Lazar. 2003. Knowing hatred.. https://doi.org/10.1516/002075703321632982

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Affective style and in vivo immune response: neurobehavioral mechanisms.

Considerable evidence exists to support an association between psychological states and immune function. However, the mechanisms by which such states are instantiated in the brain and influence the immune system are poorly understood. The present study investigated relations among physiological measures of affective style, psychological well being, and immune function. Negative and positive affect were elicited by using an autobiographical writing task. Electroencephalography and affect-modulated eye-blink startle were used to measure trait and state negative affect. Participants were vaccinated for influenza, and antibody titers after the vaccine were assayed to provide an in vivo measure of immune function. Higher levels of right-prefrontal electroencephalographic activation and greater magnitude of the startle reflex reliably predicted poorer immune response. These data support the hypothesis that individuals characterized by a more negative affective style mount a weaker immune response and therefore may be at greater risk for illness than those with a more positive affective style.

Affect↗

Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.

OBJECTIVE: Medication nonadherence presents a considerable problem in patients with schizophrenia. There are limited and conflicting data on the association of cognitive impairment with antipsychotic nonadherence. In this study, we evaluated the correlation of patients' scores on Mattis' Dementia Rating Scale (DRS; total and subscale scores) with scores on the Medication Management Ability Assessment (MMAA), a performance-based measure of medication management. METHODS: Participants included 110 outpatients with schizophrenia or schizoaffective disorder. Each was evaluated using the MMAA role-play tasks and the DRS. Patients also completed the Drug Attitude Inventory (DAI), and the PANSS (Positive And Negative Syndrome Scale). RESULTS: Age, DAI score, and DRS scores were all correlated with MMAA performance. In a stepwise regression analysis, only DRS scores were predictive of MMAA performance. Among the DRS subscales, conceptualization and memory were the best statistical predictors of MMAA performance. CONCLUSION: Cognitive functions, especially conceptualization and memory, were the strongest patient-related predictors of his or her ability to manage medications, over and above the effects of age, gender, education level, symptom severity, and attitudes toward medications. These results suggest a need for intervention studies focused on improving, or at least compensating for, specific cognitive deficits such as those in memory and conceptualization among patients with schizophrenia in order to improve their ability to manage medications.

Affect↗